Keywords: france, ipsen, sees, sales, growth, french, drugmaker
France's Ipsen sees 8.6% sales growth
Article | 16 May 2005
French drugmaker Ipsen has said sales for 2004 reached 770.2 million euros ($988.4 million), a rise of 8.6% compared with 2003 on a constant perimeter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
